Biotechnology Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences May 26, 2022
Biotechnology Bio-Techne Celebrates 40,000 Unique RNAscope(TM) in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species. May 26, 2022
Biotechnology AXSM INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Axsome Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit May 26, 2022
Biotechnology Galapagos to showcase commitment to rheumatoid arthritis care at the upcoming European League Against Rheumatism congress May 25, 2022
Biotechnology The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BKKT, UPST and AXSM May 25, 2022
Search
Biotechnology
